Cargando…

Pharmacokinetics of Single Oral Dose Extended‐Release Levetiracetam in Healthy Cats

BACKGROUND: Repeated PO dosing of anti‐epileptic drugs may contribute to poor compliance in treated cats. Intermediate‐release levetiracetam has been used safely in cats, but must be given q8h to maintain serum concentrations in the therapeutic interval for humans (5–45 μg/mL). Approved extended‐rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnard, L., Barnes Heller, H., Boothe, D.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787171/ https://www.ncbi.nlm.nih.gov/pubmed/29114943 http://dx.doi.org/10.1111/jvim.14863

Ejemplares similares

Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats
por: Barnes Heller, Heidi, et al.
Publicado: (2018)

Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing
por: Beasley, M.J., et al.
Publicado: (2015)

Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats
por: Smith, Casey, et al.
Publicado: (2019)

Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide
por: Muñana, Karen R., et al.
Publicado: (2018)

Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016)

Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
por: Roche‐Catholy, Marine, et al.
Publicado: (2022)

Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration
por: Woerde, Dennis J., et al.
Publicado: (2022)

The pharmacokinetics of gabapentin in cats
por: Adrian, Derek, et al.
Publicado: (2018)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Pharmacokinetics of mycophenolic acid and its effect on CD4(+) and CD8(+) T cells after oral administration of mycophenolate mofetil to healthy cats
por: Slovak, Jennifer E., et al.
Publicado: (2019)

Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus
por: Riederer, A., et al.
Publicado: (2016)

Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
por: Krämer, Anna L., et al.
Publicado: (2020)

In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease
por: Fitzpatrick, Rikki L., et al.
Publicado: (2018)

Levetiracetam‐responsive paroxysmal exertional dyskinesia in a Welsh Terrier
por: Green, Sherril, et al.
Publicado: (2021)

Effects of a single subcutaneous dose of enoxaparin on veterinary viscoelastic coagulation monitor variables in healthy cats: Double blind, placebo controlled cross‐over trial
por: Yozova, Ivayla D., et al.
Publicado: (2022)

Microbiome analysis of bile from apparently healthy cats and cats with suspected hepatobiliary disease
por: Slead, Tanner S., et al.
Publicado: (2023)

Effects of oral administration of 5 immunosuppressive agents on activated T‐cell cytokine expression in healthy dogs
por: Archer, Todd M., et al.
Publicado: (2020)

Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs
por: Hasbach, A.E., et al.
Publicado: (2017)

Stability and profiling of urinary microRNAs in healthy cats and cats with pyelonephritis or other urological conditions
por: Jessen, Lisbeth R., et al.
Publicado: (2019)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Ampicillin pharmacokinetics in azotemic and healthy dogs
por: Monaghan, Kelly N., et al.
Publicado: (2021)

Blood Pressure Measurements in 780 Apparently Healthy Cats
por: Payne, J.R., et al.
Publicado: (2016)

Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs
por: Hwang, J.‐H., et al.
Publicado: (2017)

Pasireotide Long‐Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism
por: Gostelow, R., et al.
Publicado: (2017)

Computed tomographic appearance of abdominal lymph nodes in healthy cats
por: Perlini, Michael, et al.
Publicado: (2018)

Assessment of serum symmetric dimethylarginine and creatinine concentrations in hyperthyroid cats before and after a fixed dose of orally administered radioiodine
por: Yu, Lucia, et al.
Publicado: (2020)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism
por: Peterson, Mark E., et al.
Publicado: (2021)

Open‐label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures
por: Cagnotti, Giulia, et al.
Publicado: (2019)

Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma
por: Prego, Maria Teresa, et al.
Publicado: (2023)

Validation of Ultrasonography for Assessment of Gastric Emptying Time in Healthy Cats by Radionuclide Scintigraphy
por: Husnik, R., et al.
Publicado: (2017)

Pancreatic enzyme activity in the bile of healthy cats and its association with biliary morphology
por: Fujimoto, Shinsuke, et al.
Publicado: (2021)

Ultrasonographic evaluation of the effects of azithromycin on antral motility and gastric emptying in healthy cats
por: Rutherford, Stephanie, et al.
Publicado: (2022)

Environmental risk factors for the development of oral squamous cell carcinoma in cats
por: Zaccone, Riccardo, et al.
Publicado: (2022)

Influence of clinical setting and cat characteristics on indirectly measured blood pressure and pulse rate in healthy Birman, Norwegian Forest, and Domestic Shorthair cats
por: Hanås, Sofia, et al.
Publicado: (2021)

Received dose variability after administration of I‐131 for treatment of hyperthyroidism in cats
por: Busser, Suzanne, et al.
Publicado: (2021)

Glucose concentrations after insulin‐induced hypoglycemia and glycemic variability in healthy and diabetic cats
por: Zini, Eric, et al.
Publicado: (2018)

Evaluation of phosphorus, calcium, and magnesium content in commercially available foods formulated for healthy cats
por: Summers, Stacie C., et al.
Publicado: (2019)

Biological variation of major gut‐derived uremic toxins in the serum of healthy adult cats
por: Summers, Stacie, et al.
Publicado: (2021)

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study
por: Fox, Philip R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d0g221541a8cgenjg84pl4pqik